United Therapeutics Corp (UTHR)

Date: O: H: L: C: Vol:

Finanzdaten der United Therapeutics Corp-Aktie (UTHR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.23%783.30	781.50	790.20	799.50	798.60
Cost Of Revenue	25.41%99.50	133.40	103.40	100.90	87.60
Gross Profit	5.51%683.80	648.10	686.80	698.60	711.00
	12.28%206.70	184.10	190.60	182.60	-
Selling, General, and Administrative	12.28%206.70	184.10	190.60	182.60	-
Research and Development	5.86%146.30	138.20	139.50	127.50	-
Costs And Expenses	0.70%452.50	455.70	433.50	411.00	434.10
Operating Income/Loss	1.53%330.80	325.80	356.70	388.50	364.50
Nonoperating Income/Loss	658.67%41.90	-7.50	87.30	49.50	43.90
Income/Loss From Continuing Operations Before Tax	17.09%372.70	318.30	444.00	438.00	408.40
Income Tax Expense/Benefit, Deferred	0.77%25.70	25.90	-	-	-
Income Tax Expense/Benefit	8.53%39.70	43.40	79.70	99.30	98.90
	21.13%333.00	274.90	364.30	338.70	309.50
Attributable To Parent	21.13%333.00	274.90	364.30	338.70	309.50
Basic Average Shares	2.07%42.60	43.50	-	43.80	45.10
Diluted Average Shares	2.97%45.80	47.20	-	47.30	48.30
Basic Earnings Per Share	23.73%7.82	6.32	-	7.73	6.86
Diluted Earnings Per Share	24.91%7.27	5.82	-	7.16	6.41